Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022. Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan. The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider. Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Objects of the Issue:
The objectives of the Offer are to:
Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.
HSL Mobile App 
